PTH-calcium studies from India indicated that 25(OH)D levels >12 ng/mL are sufficient to maintain normocalcemia and suppress secondary hyperparathyroidism, thereby questioning the validity of global thresholds. The gene discussed is PTH; the disease is secondary hyperparathyroidism.